2,988 research outputs found
Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
Herpes zoster (HZ) is caused by reactivation of varicella zoster virus (VZV) that established latency in sensory and autonomic neurons during primary infection. In the Shingles Prevention Study (SPS), a large efficacy trial of live attenuated Oka/Merck zoster vaccine (ZVL), PCR-confirmed second episodes of HZ occurred in two of 660 placebo and one of 321 ZVL recipients with documented HZ during a mean follow-up of 3.13 years. An additional two ZVL recipients experienced a second episode of HZ in the Long-Term Persistence Substudy. All episodes of HZ were caused by wild-type VZV. The first and second episodes of HZ occurred in different dermatomes in each of these five participants, with contralateral recurrences in two. Time between first and second episodes ranged from 12 to 28 months.
One of the five participants, who was immunocompetent on study enrollment, was immunocompromised at the onset of his first and second episodes of HZ.
VZV DNA isolated from rash lesions from the first and second episodes of HZ was used to sequence the full-length VZV genomes. For the unique-sequence regions of the VZV genome, we employed target enrichment of VZV DNA, followed by deep sequencing. For the reiteration regions, we used PCR amplification and Sanger sequencing. Our analysis and comparison of the VZV genomes from the first and second episodes of HZ in each of the five participants indicate that both episodes were caused by the same VZV strain. This is consistent with the extraordinary stability of VZV during the replication phase of varicella and the subsequent establishment of latency in sensory ganglia throughout the body. Our observations also indicate that VZV is stable during the persistence of latency and the subsequent reactivation and replication that results in HZ
Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness
<p>Abstract</p> <p>Background</p> <p>Asthmatics exhibit reduced airway dilation at maximal inspiration, likely due to structural differences in airway walls and/or functional differences in airway smooth muscle, factors that may also increase airway responsiveness to bronchoconstricting stimuli. The goal of this study was to test the hypothesis that the minimal airway resistance achievable during a maximal inspiration (R<sub>min</sub>) is abnormally elevated in subjects with airway hyperresponsiveness.</p> <p>Methods</p> <p>The R<sub>min </sub>was measured in 34 nonasthmatic and 35 asthmatic subjects using forced oscillations at 8 Hz. R<sub>min </sub>and spirometric indices were measured before and after bronchodilation (albuterol) and bronchoconstriction (methacholine). A preliminary study of 84 healthy subjects first established height dependence of baseline R<sub>min </sub>values.</p> <p>Results</p> <p>Asthmatics had a higher baseline R<sub>min </sub>% predicted than nonasthmatic subjects (134 ± 33 vs. 109 ± 19 % predicted, p = 0.0004). Sensitivity-specificity analysis using receiver operating characteristic curves indicated that baseline R<sub>min </sub>was able to identify subjects with airway hyperresponsiveness (PC<sub>20 </sub>< 16 mg/mL) better than most spirometric indices (Area under curve = 0.85, 0.78, and 0.87 for R<sub>min </sub>% predicted, FEV<sub>1 </sub>% predicted, and FEF<sub>25-75 </sub>% predicted, respectively). Also, 80% of the subjects with baseline R<sub>min </sub>< 100% predicted did not have airway hyperresponsiveness while 100% of subjects with R<sub>min </sub>> 145% predicted had hyperresponsive airways, regardless of clinical classification as asthmatic or nonasthmatic.</p> <p>Conclusions</p> <p>These findings suggest that baseline R<sub>min</sub>, a measurement that is easier to perform than spirometry, performs as well as or better than standard spirometric indices in distinguishing subjects with airway hyperresponsiveness from those without hyperresponsive airways. The relationship of baseline R<sub>min </sub>to asthma and airway hyperresponsiveness likely reflects a causal relation between conditions that stiffen airway walls and hyperresponsiveness. In conjunction with symptom history, R<sub>min </sub>could provide a clinically useful tool for assessing asthma and monitoring response to treatment.</p
Dynamics of Transformation from Segregation to Mixed Wealth Cities
We model the dynamics of the Schelling model for agents described simply by a
continuously distributed variable - wealth. Agents move to neighborhoods where
their wealth is not lesser than that of some proportion of their neighbors, the
threshold level. As in the case of the classic Schelling model where
segregation obtains between two races, we find here that wealth-based
segregation occurs and persists. However, introducing uncertainty into the
decision to move - that is, with some probability, if agents are allowed to
move even though the threshold level condition is contravened - we find that
even for small proportions of such disallowed moves, the dynamics no longer
yield segregation but instead sharply transition into a persistent mixed wealth
distribution. We investigate the nature of this sharp transformation between
segregated and mixed states, and find that it is because of a non-linear
relationship between allowed moves and disallowed moves. For small increases in
disallowed moves, there is a rapid corresponding increase in allowed moves, but
this tapers off as the fraction of disallowed moves increase further and
finally settles at a stable value, remaining invariant to any further increase
in disallowed moves. It is the overall effect of the dynamics in the initial
region (with small numbers of disallowed moves) that shifts the system away
from a state of segregation rapidly to a mixed wealth state.
The contravention of the tolerance condition could be interpreted as public
policy interventions like minimal levels of social housing or housing benefit
transfers to poorer households. Our finding therefore suggests that it might
require only very limited levels of such public intervention - just sufficient
to enable a small fraction of disallowed moves, because the dynamics generated
by such moves could spur the transformation from a segregated to mixed
equilibrium.Comment: 12 pages, 7 figure
The Semi-Chiral Quotient, Hyperkahler Manifolds and T-duality
We study the construction of generalized Kahler manifolds, described purely
in terms of N=(2,2) semichiral superfields, by a quotient using the semichiral
vector multiplet. Despite the presence of a b-field in these models, we show
that the quotient of a hyperkahler manifold is hyperkahler, as in the usual
hyperkahler quotient. Thus, quotient manifolds with torsion cannot be
constructed by this method. Nonetheless, this method does give a new
description of hyperkahler manifolds in terms of two-dimensional N=(2,2) gauged
non-linear sigma models involving semichiral superfields and the semichiral
vector multiplet. We give two examples: Eguchi-Hanson and Taub-NUT. By
T-duality, this gives new gauged linear sigma models describing the T-dual of
Eguchi-Hanson and NS5-branes. We also clarify some aspects of T-duality
relating these models to N=(4,4) models for chiral/twisted-chiral fields and
comment briefly on more general quotients that can give rise to torsion and
give an example.Comment: 31 page
MHC immunoevasins: protecting the pathogen reservoir in infection
Alteration of antigen recognition by T cells as result of insufficient major histocompatibility complex (MHC)-dependent antigen-presenting function has been observed in many cases of infections, particularly in in vitro systems. To hide themselves from an efficient immune response, pathogens may act on MHC-related functions at three levels: (i) by limiting the number of potential antigens that can be presented to naive T cells; (ii) by synthesizing proteins which directly affect MHC cell-surface expression; and (iii) by altering the normal intracellular pathway of peptide loading on MHC. Here, we review examples of pathogens' action on each single step of MHC function and we suggest that the result of these often synergistic actions is both a limitation of the priming of naive T cells and, more importantly, a protection of the pathogen's reservoir from the attack of primed T cells. The above mechanisms may also generate a skewing effect on immune effector mechanisms, which helps preserving the reservoir of infection from sterilization by the immune system
Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells
We have previously reported that the putative cytoprotective protease inhibitor, plasminogen activator inhibitor type 2 (PAI-2), is specifically cleaved during okadaic acid-induced apoptosis in a myeloid leukaemic cell line (Br J Cancer (1994) 70: 834–840). HL-60 cells exposed to okadaic acid and camptothecin underwent morphological and biochemical changes typical of apoptosis, including internucleosomal DNA fragmentation and PAI-2 cleavage. Significant endogenous PAI-2 cleavage was observed 9 h after exposure to okadaic acid; thus correlating with other signs of macromolecular degradation, like internucleosomal DNA fragmentation. In camptothecin-treated cells, PAI-2 cleavage was an early event, detectable after 2 h of treatment, and preceding internucleosomal DNA fragmentation. The caspase I selective protease inhibitor, YVAD-cmk, inhibited internucleosomal DNA fragmentation and PAI-2 cleavage of okadaic acid and camptothecin-induced apoptotic cells. YVAD-cmk rather sensitively and non-toxically inhibited camptothecin-induced morphology, but not okadaic acid-induced morphology. In in vitro experiments recombinant PAI-2 was not found to be a substrate for caspase I. The results suggest that caspase I selective protease inhibition could antagonize parameters coupled to the execution phase of okadaic acid- and camptothecin-induced apoptosis, but not the commitment to cell death. © 1999 Cancer Research Campaig
Effective action of three-dimensional extended supersymmetric matter on gauge superfield background
We study the low-energy effective actions for gauge superfields induced by
quantum N=2 and N=4 supersymmetric matter fields in three-dimensional Minkowski
space. Analyzing the superconformal invariants in the N=2 superspace we propose
a general form of the N=2 gauge invariant and superconformal effective action.
The leading terms in this action are fixed by the symmetry up to the
coefficients while the higher order terms with respect to the Maxwell field
strength are found up to one arbitrary function of quasi-primary N=2
superfields constructed from the superfield strength and its covariant spinor
derivatives. Then we find this function and the coefficients by direct quantum
computations in the N=2 superspace. The effective action of N=4 gauge multiplet
is obtained by generalizing the N=2 effective action.Comment: 1+27 pages; v2: minor corrections, references adde
The role of healthcare professionals in encouraging parents to see and hold their stillborn baby: a meta-synthesis of qualitative studies.
Background: Globally, during 2013 there were three million recorded stillbirths. Where clinical guidelines exist some recommend that professionals do not encourage parental contact. The guidance is based on quantitative evidence that seeing and holding the baby is not beneficial for everyone, but has been challenged by bereaved parents' organisations. We aim to inform future guideline development through a synthesis of qualitative studies reporting data relevant to the research question; how does the approach of healthcare professionals to seeing and holding the baby following stillbirth impact parents views and experiences?
Methods/Findings: Using a predetermined search strategy of PubMed and PsychINFO we identified robust qualitative studies reporting bereaved parental views and/or experiences relating to seeing and holding their stillborn baby (final search 24 February, 2014). Eligible studies were English language, reporting parental views, with gestational loss >20weeks. Quality was independently assessed by three authors using a validated tool. We used meta-ethnographic techniques to identify key themes and a line of argument synthesis. We included 12 papers, representing the views of 333 parents (156 mothers, 150 fathers, and 27 couples) from six countries. The final themes were: "[Still]birth: Nature of care is paramount", "Real babies: Perfect beauties, monsters and spectres", and "Opportunity of a lifetime lost." Our line-of-argument synthesis highlights the contrast between all parents need to know their baby, with the time around birth being the only time memories can be made, and the variable ability that parents have to articulate their preferences at that time. Thus, we hypothesised that how health professionals approach contact between parents and their stillborn baby demands a degree of active management. An important limitation of this paper is all included studies originated from high income, westernised countries raising questions about the findings transferability to other cultural contexts. We do not offer new evidence to answer the question "Should parents see and hold their stillborn baby?", instead our findings advance understanding of how professionals can support parents to make appropriate decisions in a novel, highly charged and dynamic situation.
Conclusions: Guidelines could be more specific in their recommendations regarding parental contact. The role of healthcare professionals in encouraging parents to see and hold their stillborn baby is paramount. Parental choice not to see their baby, apprehension, or uncertainty should be continuously revisited in the hours after birth as the opportunity for contact is fleeting and final
Consumption patterns of sweet drinks in a population of Australian children and adolescents (2003–2008)
<p>Abstract</p> <p>Background</p> <p>Intake of sweet drinks has previously been associated with the development of overweight and obesity among children and adolescents. The present study aimed to assess the consumption pattern of sweet drinks in a population of children and adolescents in Victoria, Australia.</p> <p>Methods</p> <p>Data on 1,604 children and adolescents (4–18 years) from the comparison groups of two quasi-experimental intervention studies from Victoria, Australia were analysed<it>.</it> Sweet drink consumption (soft drink and fruit juice/cordial) was assessed as one day’s intake and typical intake over the last week or month at two time points between 2003 and 2008 (mean time between measurement: 2.2 years).</p> <p>Results</p> <p>Assessed using dietary recalls, more than 70% of the children and adolescents consumed sweet drinks, with no difference between age groups (p = 0.28). The median intake among consumers was 500 ml and almost a third consumed more than 750 ml per day. More children and adolescents consumed fruit juice/cordial (69%) than soft drink (33%) (p < 0.0001) and in larger volumes (median intake fruit juice/cordial: 500 ml and soft drink: 375 ml). Secular changes in sweet drink consumption were observed with a lower proportion of children and adolescents consuming sweet drinks at time 2 compared to time 1 (significant for age group 8 to <10 years, p = 0.001).</p> <p>Conclusion</p> <p>The proportion of Australian children and adolescents from the state of Victoria consuming sweet drinks has been stable or decreasing, although a high proportion of this sample consumed sweet drinks, especially fruit juice/cordial at both time points.</p
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
A major challenge in developing vaccines for emerging pathogens is their continued evolution and ability to escape human immunity. Therefore, an important goal of vaccine research is to advance vaccine candidates with sufficient breadth to respond to new outbreaks of previously undetected viruses. Ebolavirus (EBOV) vaccines have demonstrated protection against EBOV infection in nonhuman primates (NHP) and show promise in human clinical trials but immune protection occurs only with vaccines whose antigens are matched to the infectious challenge species. A 2007 hemorrhagic fever outbreak in Uganda demonstrated the existence of a new EBOV species, Bundibugyo (BEBOV), that differed from viruses covered by current vaccine candidates by up to 43% in genome sequence. To address the question of whether cross-protective immunity can be generated against this novel species, cynomolgus macaques were immunized with DNA/rAd5 vaccines expressing ZEBOV and SEBOV glycoprotein (GP) prior to lethal challenge with BEBOV. Vaccinated subjects developed robust, antigen-specific humoral and cellular immune responses against the GP from ZEBOV as well as cellular immunity against BEBOV GP, and immunized macaques were uniformly protected against lethal challenge with BEBOV. This report provides the first demonstration of vaccine-induced protective immunity against challenge with a heterologous EBOV species, and shows that Ebola vaccines capable of eliciting potent cellular immunity may provide the best strategy for eliciting cross-protection against newly emerging heterologous EBOV species
- …